Scancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Says auditor request additional time to complete standard audit of its results of financial year 2023 that ended.
Lenders Barclays, Lloyds Banking, NatWest and StanChart are among the headline acts in London s financial agenda for the coming week, while across the pond,.
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), which is developing immunotherapies for cancer and infectious disease, said its chief executive and chief.